Esperion Therapeutics (ESPR) shares were up over 15% in recent Tuesday trading after Piper Sandler began coverage of the healthcare company's stock with an overweight rating and a $9 price target.
The company's trading volume for the day stood at about 13.8 million shares against a daily average of roughly 7 million.
Price: 3.67, Change: +0.50, Percent Change: +15.62